Literature DB >> 2024472

Indiscriminate activity from the B19 parvovirus p6 promoter in nonpermissive cells.

J M Liu1, H Fujii, S W Green, N Komatsu, N S Young, T Shimada.   

Abstract

B19 parvovirus is absolutely tropic for human erythroid progenitor cells. Among the untested mechanisms underlying this tropism is the possibility of cell-specific positive regulation of the promoter in permissive cells. Using the bacterial chloramphenicol acetyltransferase and firefly luciferase reporter genes, we detected strong activity from the B19 P6 promoter in transfected nonpermissive cells. Very high-level expression was seen in a T lymphoblastoid cell line, CEM. No transcriptional enhancement occurred in an erythropoietin-dependent semipermissive cell line. A putative second B19 promoter at map unit 44 (P44) was nonfunctional and unable to confer tissue specificity. Thus, tropism is unlikely to be regulated at the level of transcriptional initiation from either the P6 or P44 promoter.

Entities:  

Mesh:

Year:  1991        PMID: 2024472     DOI: 10.1016/0042-6822(91)90682-2

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  15 in total

1.  A block in full-length transcript maturation in cells nonpermissive for B19 parvovirus.

Authors:  J M Liu; S W Green; T Shimada; N S Young
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

2.  Targeted and highly efficient gene transfer into CD4+ cells by a recombinant human immunodeficiency virus retroviral vector.

Authors:  T Shimada; H Fujii; H Mitsuya; A W Nienhuis
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

3.  The 3' untranslated region of the B19 parvovirus capsid protein mRNAs inhibits its own mRNA translation in nonpermissive cells.

Authors:  C Pallier; A Greco; J Le Junter; A Saib; I Vassias; F Morinet
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

4.  Long-term systemic therapy of Fabry disease in a knockout mouse by adeno-associated virus-mediated muscle-directed gene transfer.

Authors:  Hiroshi Takahashi; Yukihiko Hirai; Makoto Migita; Yoshihiko Seino; Yuh Fukuda; Hitoshi Sakuraba; Ryoichi Kase; Toshihide Kobayashi; Yasuhiro Hashimoto; Takashi Shimada
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-07       Impact factor: 11.205

5.  Established immunity precludes adenovirus-mediated gene transfer in rat carotid arteries. Potential for immunosuppression and vector engineering to overcome barriers of immunity.

Authors:  A H Schulick; G Vassalli; P F Dunn; G Dong; J J Rade; C Zamarron; D A Dichek
Journal:  J Clin Invest       Date:  1997-01-15       Impact factor: 14.808

Review 6.  Human Parvoviruses.

Authors:  Jianming Qiu; Maria Söderlund-Venermo; Neal S Young
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

7.  Characterization of cis-acting and NS1 protein-responsive elements in the p6 promoter of parvovirus B19.

Authors:  R Gareus; A Gigler; A Hemauer; M Leruez-Ville; F Morinet; H Wolf; S Modrow
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

8.  Cloning, genomic organization, and osmotic response of the aldose reductase gene.

Authors:  J D Ferraris; C K Williams; B M Martin; M B Burg; A García-Pérez
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-25       Impact factor: 11.205

9.  Vulnerability of the human airway epithelium to hyperoxia. Constitutive expression of the catalase gene in human bronchial epithelial cells despite oxidant stress.

Authors:  J H Yoo; S C Erzurum; J G Hay; P Lemarchand; R G Crystal
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808

10.  Modulation of secretory leukoprotease inhibitor gene expression in human bronchial epithelial cells by phorbol ester.

Authors:  M Maruyama; J G Hay; K Yoshimura; C S Chu; R G Crystal
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.